Zobrazeno 1 - 1
of 1
pro vyhledávání: '"amlanivimab-etesevimab"'
Autor:
Savoldi, Alessia, Morra, Matteo, De Nardo, Pasquale, Cattelan, Anna Maria, Mirandola, Massimo, Manfrin, Vinicio, Scotton, Piergiorgio, Giordani, Maria Teresa, Brollo, Lucio, Panese, Sandro, Lanzafame, Massimiliano, Scroccaro, Giovanna, Berkell, Matilda, Lippi, Giuseppe, Konnova, Angelina, Smet, Mathias, Malhotra-Kumar, Surbhi, Kumar-Singh, Samir, Tacconelli, Evelina, Canova, Marco, Rigo, Fabio, Coletto, Davide, Serino, Francesco Saverio, Coledan, Ilaria, Danese, Elisa, Peserico, Denise, Gelati, Matteo, Conti, Michela, Fasan, Daniele, Xavier, Basil Britto, Gupta, Akshita, Hotterbeekx, An, De Ambrosis, Paola
Publikováno v:
European journal of clinical microbiology and infectious diseases
This study aimed to compare the clinical progression of COVID-19 in high-risk outpatients treated with the monoclonal antibodies (mAb) bamlanivimab, bamlanivimab-etesevimab and casirivimab-imdevimab. This is an observational, multi-centre, prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1742d455c5bc02f813638a27eec463a
http://hdl.handle.net/11562/1068927
http://hdl.handle.net/11562/1068927
